Linda Jordan
Internal Medicine · Jamestown, NYNPI 1568593010
Payments from drug & device makers
Across 97 payments — averaging $32.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$365
- AbbVie$287
- Sanofi$238
- Lundbeck LLC$198
- Shield Therapeutics Inc$143
- Idorsia Pharmaceuticals US Inc$134
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,189100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3 | $365 |
| AbbVie | 10 | $287 |
| Sanofi | 2 | $238 |
| Lundbeck LLC | 12 | $198 |
| Shield Therapeutics Inc | 7 | $143 |
| Idorsia Pharmaceuticals US Inc | 3 | $134 |
| Johnson & Johnson | 1 | $126 |
| Exact Sciences | 5 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Neurocrine Biosciences, Inc. | 1 | $118 |
| Boston Scientific | 1 | $112 |
| Gilead | 4 | $112 |
| Smith+Nephew | 1 | $107 |
| Lilly USA, LLC | 5 | $105 |
| Astellas Pharma US Inc | 4 | $104 |
| Pfizer | 4 | $88 |
| Sanofi-aventis U.S. LLC | 1 | $75 |
| GSK | 3 | $75 |
| Biogen | 3 | $73 |
| AstraZeneca | 3 | $71 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Bausch Health US, LLC | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Amgen | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Novo Nordisk | 1 | $28 |
| Insmed, Inc. | 1 | $25 |
| Viiv Healthcare Company | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,189 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 61 | $396 |
| Rosuvastatin Calcium | 21 | $377 |
| Levothyroxine Sodium | 22 | $252 |
| Lisinopril | 22 | $221 |
| Atorvastatin Calcium | 25 | $112 |
| Amlodipine Besylate | 18 | $93 |
| Clonazepam | 22 | $84 |
| Metformin Hcl | 12 | $61 |
| Alprazolam | 12 | $55 |
| Omeprazole | 16 | $42 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Jamestown
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.